Keap1: One stone kills three birds Nrf2, IKKβ and Bcl-2/Bcl-xL

Cancer Letters

Volumn 325, Issue 1, 2012, Pages 26-34

  Tian, Hui ^a   Zhang, BaoFu ^a   Di, JieHui ^a   Jiang, Guan ^a   Chen, FeiFei ^a   Li, HuiZhong ^a   Li, LianTao ^a   Pei, DongSheng ^a   Zheng, JunNian ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Bcl 2 Bcl xL; IKK ; Keap1; Nrf2

Indexed keywords

ANTIOXIDANT; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; PROTEIN BCL 2; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE E3;

APOPTOSIS; CANCER CELL; CARCINOGENESIS; CELL PROTECTION; ENZYME REGULATION; ENZYME SUBSTRATE; GENE EXPRESSION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; SHORT SURVEY; SIGNAL TRANSDUCTION; SOMATIC MUTATION; TUMOR GROWTH;

AVES;

EID: 84865280525     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.06.007     Document Type: Review

References (86)

1. Burhans W.C., Weinberger M. DNA replication stress, genome instability and aging. Nucl. Acids Res. 2007, 35:7545-7556.
2. Khandrika L., Kumar B., Koul S., Maroni P., Koul H.K. Oxidative stress in prostate cancer. Cancer Lett. 2009, 282:125-136.
3. Khansari N., Shakiba Y., Mahmoudi M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Rec. Pat. Inflamm. Allergy Drug Discov. 2009, 3:73-80.
4. Pool-Zobel B., Veeriah S., Bohmer F.D. Modulation of xenobiotic metabolising enzymes by anticarcinogens focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat. Res. 2005, 591:74-92.
5. Barve A., Khor T.O., Nair S., Reuhl K., Suh N., Reddy B B., Newmark H., Kong A.N. Gamma-tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice. Int. J. Cancer 2009, 124:1693-1699.
6. Kumaraguruparan R., Seshagiri P.B., Hara Y., Nagini S. Chemoprevention of rat mammary carcinogenesis by black tea polyphenols: modulation of xenobioticmetabolizing enzymes, oxidative stress, cell proliferation, apoptosis and angiogenesis. Mol. Carcinog. 2007, 46:797-806.
7. Lee S.B., Kim C.Y., Lee H.J., Yun J.H., Nho C.W. Induction of the phase II detoxification enzyme NQO1 in hepatocarcinoma cells by lignans from the fruit of Schisandra chinensis through nuclear accumulation of Nrf2. Planta. Med. 2009, 75:1314-1318.
8. Giles G.I. The redox regulation of thiol dependent signaling pathways in cancer. Curr. Pharm. Des. 2006, 12:4427-4443.
9. Tew K.D. Redox in redux: emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation. Biochem. Pharmacol. 2007, 73:1257-1269.
10. Chan K., Han X.D., Kan Y.W. An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen. Proc. Natl. Acad. Sci. USA 2001, 98:4611-4616.
11. Dinkova-Kostova A.T., Holtzclaw W.D., Cole R.N., Itoh K., Wakabayashi N., Katoh Y., Yamamoto M., Talalay P. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens oxidants. Proc. Natl. Acad. Sci. USA 2002, 99:11908-11913.
12. Eggler A.L., Liu G., Pezzuto J.M., van Breemen R.B., Mesecar A.D. Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proc. Natl. Acad. Sci. USA 2005, 102:10070-10075.
13. Kobayashi M., Yamamoto M. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid. Red. Sign. 2005, 7:385-394.
14. Levonen A.L., Landar A., Ramachandran A., Ceaser E.K., Dickinson D.A., Zanoni G., Morrow J.D., Darley-Usmar V.M. Cellular mechanisms of redox cell signaling: role of cysteine modification incontrolling antioxidant defences in response to electrophilic lipid oxidationproducts. Biochem. J. 2004, 378:373-382.
15. Rushmore T.H., Pickett C.B. Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants. J. Biol. Chem. 1990, 265:14648-14653.
16. Ikeda H., Nishi S., Sakai M. Transcription factor Nrf2/MafK regulates rat placental glutathione S-transferase gene during hepatocarcinogenesis. Biochem. J. 2004, 380:515-521.
17. Venugopal R., Jaiswal A.K. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc. Natl. Acad. Sci. USA 1996, 93:14960-14965.
18. Wang W., Jaiswal A.K. Nuclear factor Nrf2 and antioxidant response element regulate NRH: quinone oxidoreductase 2 (NQO2) gene expression and antioxidant induction. Free Radic. Biol. Med. 2006, 40:1119-1130.
19. Banning A., Deubel S., Kluth D., Zhou Z., Brigelius-Flohé R. The GI-GPx gene is a target for Nrf2. Mol. Cell Biol. 2005, 25:4914-4923.
20. Philips J., Herskowitz I. Identification of Kel1p, a kelch domain-containing protein involved in cellfusion and morphology in Saccharomyces cerevisiae. J. Cell Biol. 1998, 143:375-389.
21. Zipper L.M., Mulcahy R.T. The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm. J. Biol. Chem. 2002, 277:36544-36552.
22. Adams J., Kelso R., Cooley L. The kelch repeat superfamily of proteins: propellers of cell function. Trends Cell Biol. 2000, 10:17-24.
23. Kim I.F., Mohammadi E., Huang R.C. Isolation and characterization of IPP, a novel human gene encoding an actin-binding, kelch-like protein. Gene 1999, 228:73-83.
24. Hayes J.D., McMahon M. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem. Sci. 2009, 34:176-188.
25. Tong K.I., Kobayashi A., Katsuoka F., Yamamoto M. Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol. Chem. 2006, 387:1311-1320.
26. Wakabayashi N., Dinkova-Kostova A.T., Holtzclaw W.D., Kang M.I., Kobayashi A., Yamamoto M., Kensler T.W., Talalay P. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of theKeap1sensor modified by inducers. Proc. Natl. Acad. Sci. USA 2004, 101:2040-2045.
27. Zhang D.D., Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell Biol. 2003, 23:8137-8151.
28. Buckley B.J., Marshall Z.M., Whorton A.R. Nitric oxide stimulates Nrf2 nuclear translocation in vascular endothelium. Biochem. Biophys. Res. Commun. 2003, 307:973-979.
29. Cortese-Krott M.M., Suschek C.V., Wetzel W., Kröncke K.D., Kolb-Bachofen V. Nitric oxide-mediated protection of endothelial cells from hydrogen peroxideis mediated by intracellular zince and glutathione. Am. J. Physiol. Cell Physiol. 2009, 296:C811-C820.
30. Dhakshinamoorthy S., Porter A.G. Nitric oxide-induced transcriptional up-regulation of protective genes by Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells. J. Biol. Chem. 2004, 279:20096-20107.
31. Liu X.M., Peyton K.J., Ensenat D., Wang H., Hannink M., Alam J., Durante W. Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survival. Cardiovasc. Res. 2007, 75:381-389.
32. Surh Y.J., Kundu J.K., Li M.H., Na H.K., Cha Y.N. Role of Nrf2-mediated heme oxygenase-1 upregulation in adaptive survival response to nitrosative stress. Arch. Pharm. Res. 2009, 32:1163-1176.
33. Um H.C., Jang J.H., Kim D.H., Lee C., Surh Y.J. Nitric oxide activates Nrf2 through S-nitrosylation of Keap1 in PC12 cells. Nitric Oxide 2011, 25:161-168.
34. Jain A.K., Mahajan S., Jaiswal A.K. Phosphorylation and dephosphorylation oftyrosine141 regulate stability and degradation ofINrf2: a novel mechanism in Nrf2 activation. J. Biol. Chem. 2008, 283:17712-17720.
35. Niture S.K., Jaiswal A.K. Hsp90 interaction with INrf2 (Keap1) mediates stress-induced Nrf2 activation. J. Biol. Chem. 2010, 285:36865-36875.
36. Kobayashi A., Kang M.I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., Igarashi K., Yamamoto M. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell Biol. 2004, 24:7130-7139.
37. Zhang D.D., Lo S.C., Cross J.V., Templeton D.J., Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell Biol. 2004, 24:10941-10953.
38. Motohashi H., Katsuoka F., Engel J.D., Yamamoto M. Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. Proc. Natl. Acad. Sci. USA 2004, 101:6379-6384.
39. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999, 13:76-86.
40. Ding Y., Choi K.J., Kim J.H., Han X., Piao Y., Jeong J.H., Choe W., Kang I., Ha J., Forman H.J., Lee J., Yoon K.S., Kim S.S. Endogenous hydrogen peroxide regulates glutathione redox via nuclear factor erythroid 2-related factor 2 downstream of phosphatidylinositol 3-kinase during muscle differentiation. Am. J. Pathol. 2008, 172:1529-1541.
41. Hsieh C.Y., Hsiao H.Y., Wu W.Y., Liu C.A., Tsai Y.C., Chao Y.J., Wang D.L., Hsieh H.J. Regulation of shear-induced nuclear translocation of the Nrf2 transcription factor in endothelial cells. J. Biomed. Sci. 2009, 16:12.
42. Dhakshinamoorthy S., Long D.J., Jaiswal A.K. Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens. Curr. Top Cell Regul. 2000, 36:201-216.
43. Jaiswal A.K. Regulation of genes encoding NAD(P):quinone oxidoreductases. Free Radic. Biol. Med. 2000, 29:254-262.
44. Ito N., Phillips S.E., Yadav K.D., Knowles P.F. Crystal structure of a free radical enzyme, galactose oxidase. J. Mol. Biol. 1994, 238:794-814.
45. McMahon M., Thomas N., Itoh K., Yamamoto M., Hayes J.D. Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a "tethering" mechanism: a two-site interaction model for the Nrf2-Keap1 complex. J. Biol. Chem. 2006, 281:24756-24768.
46. Tong K.I., Katoh Y., Kusunoki H., Itoh K., Tanaka T., Yamamoto M. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol. Cell Biol. 2006, 26:2887-2900.
47. Rada P., Rojo A.I., Chowdhry S., McMahon M., Hayes J.D., Cuadrado A. SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner. Mol. Cell Biol. 2011, 31:1121-1133.
48. Bloom D.A., Jaiswal A.K. Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J. Biol. Chem. 2003, 278:44675-44682.
49. Huang H.C., Nguyen T., Pickett C.B. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem. 2002, 277:42769-42774.
50. Lafuente M.J., Casterad X., Trias M., Ascaso C., Molina R., Ballesta A., Zheng S., Wiencke J.K., Lafuente A. NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors. Carcinogenesis 2000, 21:1813-1819.
51. Kang M.I., Kobayashi A., Wakabayashi N., Kim S.G., Yamamoto M. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc. Natl. Acad. Sci. USA 2004, 101:2046-2051.
52. Niture S.K., Jain A.K., Jaiswal A.K. Antioxidant-induced modification of INrf2 cysteine 151 and PKC-delta-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance. J. Cell Sci. 2009, 122:4452-4464.
53. Jain A.K., Jaiswal A.K. GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J. Biol. Chem. 2007, 282:16502-16510.
54. Kaspar J.W., Jaiswal A.K. Tyrosine phosphorylation controls nuclear export of Fyn, allowing Nrf2 activation of cytoprotective gene expression. FASEB J. 2011, 25:1076-1087.
55. Wakabayashi N., Itoh K., Wakabayashi J., Motohashi H., Noda S., Takahashi S., Imakado S., Kotsuji T., Otsuka F., Roop D.R., Harada T., Engel J.D., Yamamoto M. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet. 2003, 35:238-245.
56. Lee O.H., Jain A.K., Papusha V., Jaiswal A.K. An auto-regulatory loop between stress sensors INrf2 and Nrf2 controls their cellular abundance. J. Biol. Chem. 2007, 282:36412-36420.
57. Niture S.K., Jaiswal A.K. Prothymosin-alpha mediates nuclear import of the INrf2/Cul3 Rbx1 complex to degrade nuclear Nrf2. J. Biol. Chem. 2009, 284:13856-13868.
58. Jain A.K., Jaiswal A.K. Phosphorylation of tyrosine 568 controls nuclear export of Nrf2. J. Biol. Chem. 2006, 281:12132-12142.
59. Sun Z., Wu T., Zhao F., Lau A., Birch C.M., Zhang D.D. KPNA6 (Importin {alpha}7)-mediated nuclear import of Keap1 represses the Nrf2-dependent antioxidant response. Mol. Cell Biol. 2011, 31:1800-1811.
60. Karapetian R.N., Evstafieva A.G., Abaeva I.S., Chichkova N.V., Filonov G.S., Rubtsov Y.P., Sukhacheva E.A., Melnikov S.V., Schneider U., Wanker E.E., Vartapetian A.B. Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes. Mol. Cell Biol. 2005, 25:1089-1099.
61. Nguyen T., Sherratt P.J., Nioi P., Yang C.S., Pickett C.B. Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap. J. Biol. Chem. 2005, 280:32485-32492.
62. Sun Z., Zhang S., Chan J.Y., Zhang D.D. Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2. Mol. Cell Biol. 2007, 27:6334-6349.
63. Velichkova M., Hasson T. Keap1 regulates the oxidation-sensitive shuttling of Nrf2 into and out of the nucleus via a Crm1-dependent nuclear export mechanism. Mol. Cell Biol. 2005, 25:4501-4513.
64. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
65. Hagemann T., Biswas S.K., Lawrence T., Sica A., Lewis C.E. Regulation of macrophage function in tumors: the multifaceted role of NfkappaB. Blood 2009, 113:3139-3146.
66. Antunes F., Han D. Redox regulation of NFkappaB: from basic to clinical research. Antioxid. Red. Sign. 2009, 11:2055-2056.
67. Mauro C., Zazzeroni F., Papa S., Bubici C., Franzoso G. The NFkappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NFkappaB activity. Meth. Mol. Biol. 2009, 512:169-207.
68. Kiessling M.K., Klemke C.D., Kaminski M.M., Galani I.E., Krammer P.H., Gulow K. Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma. Cancer Res. 2009, 69:2365-2374.
69. Park S.A., Na H.K., Kim E.H., Cha Y.N., Surh Y.J. 4-hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of IkappaB kinase: potential role of reactive oxygen species. Cancer Res. 2009, 69:2416-2424.
70. Lee D.F., Kuo H.P., Liu M., Chou C.K., Xia W., Du Y., Shen J., Chen C.T., Huo L., Hsu M.C., Li C.W., Ding Q., Liao T.L., Lai C.C., Lin A.C., Chang Y.H., Tsai S.F., Li L.Y., Hung M.C. KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta. Mol. Cell 2009, 36:131-140.
71. Hu M.C., Lee D.F., Xia W., Golfman L.S., Ou-Yang F., Yang J.Y., Zou Y., Bao S., Hanada N., Saso H., Kobayashi R., Hung M.C. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 2004, 117:225-237.
72. Lee D.F., Kuo H.P., Chen C.T., Hsu J.M., Chou C.K., Wei Y., Sun H.L., Li L.Y., Ping B., Huang W.C., He X., Hung J.Y., Lai C.C., Ding Q., Su J.L., Yang J.Y., Sahin A.A., Hortobagyi G.N., Tsai F.J., Tsai C.H., Hung M.C. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 2007, 130:440-455.
73. Xia Y., Padre R.C., De Mendoza T.H., Bottero V., Tergaonkar V.B., Verma I.M. Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP. Proc. Natl. Acad. Sci. USA 2009, 106:2629-2634.
74. Muchmore S.W., Sattler M., Liang H., Meadows R.P., Harlan J.E., Yoon H.S., Nettesheim D., Chang B.S., Thompson C.B., Wong S.L., Ng S.L., Fesik S.W. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 1996, 381:335-341.
75. Niture S.K., Jaiswal A.K. Inhibitor of Nrf2 (INrf2 or Keap1) protein degrades Bcl-xL via phosphoglycerate mutase 5 and controls cellular apoptosis. J. Biol. Chem. 2011, 286:44542-44556.
76. Niture S.K., Jaiswal A.K. INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis. Cell Death Differ. 2011, 18:439-451.
77. Ito T., Deng X., Carr B., May W.S. Bcl-2 phosphorylation required for anti-apoptosis function. J. Biol. Chem. 1997, 272:11671-11673.
78. Mai H., May W.S., Gao F., Jin Z., Deng X. A functional role for nicotine in Bcl2 phosphorylation and suppression of apoptosis. J. Biol. Chem. 2003, 278:1886-1891.
79. Singh A., Misra V., Thimmulappa R.K., Lee H., Ames S., Hoque M.O., Herman J.G., Baylin S.B., Sidransky D., Gabrielson E., Brock M.V., Biswal S. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med. 2006, 3:e420.
80. Wang W., Chan J.Y. Nrf1 is targeted to the endoplasmic reticulum membrane by an N-terminal transmembrane domain. Inhibition of nuclear translocation and transacting function. J. Biol. Chem. 2006, 281:19676-19687.
81. Lo S.C., Hannink M. PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated Keap1-dependent ubiquitin ligase complex. J. Biol. Chem. 2006, 281:37893-37903.
82. Ohta T., Iijima K., Miyamoto M., Nakahara I., Tanaka H., Ohtsuji M., Suzuki T., Kobayashi A., Yokota J., Sakiyama T., Shibata T., Yamamoto M., Hirohashi S. Loss of Keap1 function activates Nrf2 a nd provides advantages for lung cancer cell growth. Cancer Res. 2008, 68:1303-1309.
83. Padmanabhan B., Tong K.I., Ohta T., Nakamura Y., Scharlock M., Ohtsuji M., Kang M.I., Kobayashi A., Yokoyama S., Yamamoto M. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol. Cell 2006, 21:689-700.
84. Wood L.D., Parsons D.W., Jones S., Lin J., Sjoblom T., Leary R.J., Shen D., Boca S.M., Barber T., J Ptak, Silliman N., Szabo S., Dezso Z., Ustyanksky V., T Nikolskaya, Nikolsky Y., Karchin R., Wilson P.A., Kaminker J.S., Zhang Z., Croshaw R., Willis J., Dawson D., Shipitsin M., Willson J.K., Sukumar S., Polyak K., Park B.H., Pethiyagoda C.L., Pant P.V., Ballinger D.G., Sparks A.B., Hartigan J., Smith D.R., Suh E., Papadopoulos N., Buckhaults P., Markowitz S.D., Parmigiani G., Kinzler K.W., Velculescu V.E., Vogelstein B. The genomic landscapes of human breast and colorectal cancers. Science 2007, 318:1108-1113.
85. Nioi P., Nguyen T. A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity. Biochem. Biophys. Res. Commun. 2007, 362:816-821.
86. Shibata T., Kokubu A., Gotoh M., Ojima H., Ohta T., Yamamoto M., Hirohashi S. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 2008, 135:1358-1368.